Corticosteroid Injections for Epicondylitis: Use Cautiously for Short-Term Relief Only
Corticosteroid injections provide effective short-term pain relief (2-6 weeks) for both lateral and medial epicondylitis but offer no long-term benefit and may result in worse outcomes than conservative management after 6 months 1, 2, 3.
Key Clinical Evidence
Lateral Epicondylitis (Tennis Elbow)
Short-term efficacy (≤6 weeks):
- Corticosteroid injections demonstrate superior pain reduction, functional improvement, and overall success rates (92%) compared to physiotherapy (47%) and wait-and-see approaches (32%) 3
- More effective than NSAIDs and placebo injections for immediate symptom control 1, 2, 4
Long-term outcomes (≥6 months):
- High recurrence rates with significantly worse outcomes than physiotherapy at 52 weeks: 69% success for injections versus 91% for physiotherapy 3
- No beneficial effects demonstrated for intermediate (6 weeks-6 months) or long-term follow-up 2, 4
- Patients treated with corticosteroids show inferior pain and functional outcomes compared to those who received physiotherapy or even watchful waiting 3
Medial Epicondylitis (Golfer's Elbow)
The evidence is more limited but follows a similar pattern:
- Single injection of 40mg methylprednisolone with lidocaine provides significantly less pain at 6 weeks compared to placebo (p < 0.03) 5
- No difference in pain at 3 months or 1 year, suggesting the improvement primarily reflects natural history rather than treatment effect 5
Practical Injection Protocol (When Used)
Indications:
- Acute phase epicondylitis requiring rapid symptom control
- Failed conservative management with NSAIDs and activity modification
- Patient requires short-term functional improvement for specific activities
Regimen:
- Dosage: 40mg methylprednisolone (or equivalent corticosteroid) mixed with 1% lidocaine
- Frequency: Single injection initially; avoid more than 3-4 injections per year in the same location 6
- Technique: Peritendinous injection (not intratendinous to minimize tendon damage risk)
Post-injection care:
- Avoid overuse of injected area for 24 hours, but immobilization is discouraged 6
- Normal activity can resume after 24-48 hours
Critical Warnings and Pitfalls
Adverse effects:
- Skin atrophy risk (reported in 82% of corticosteroid injection trials) 4
- Potential tendon weakening with repeated injections
- High recurrence rates necessitating additional interventions
Special populations:
- Diabetic patients: Monitor glucose levels closely for 1-3 days post-injection due to transient hyperglycemia risk 6
- Pre-surgical patients: Avoid injections within 3 months of planned elbow surgery due to increased infection risk 6
Recommended Treatment Algorithm
- First-line (0-6 weeks): Activity modification, NSAIDs, and physiotherapy with eccentric exercises
- Consider corticosteroid injection IF: Acute severe pain requiring rapid relief for functional necessity
- Mandatory concurrent treatment: Initiate physiotherapy immediately alongside or after injection
- Long-term management: Transition to physiotherapy-based rehabilitation regardless of initial injection response, as physiotherapy demonstrates superior 12-month outcomes 3
Alternative Considerations
Recent evidence suggests hyaluronic acid may provide superior medium-to-long-term outcomes (8 weeks to 6 months) compared to corticosteroids in acute lateral epicondylitis, though the evidence quality is very low 7. Platelet-rich plasma shows better long-term results than corticosteroids at 3-6 months but slower initial relief 8, 9.
The fundamental clinical message: Corticosteroid injections are a short-term rescue intervention, not a definitive treatment. Patients must understand that while injections provide rapid symptom relief, they do not alter the disease course and may compromise long-term outcomes if used as standalone therapy 5, 3.